Lysine

Lysine

SCHEMBL9346943

CC(C)Cc1ccc(CCC(=O)O)cc1.NCCCC[C@H](N)C(=O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 known ✓ P23219 3/20 0.43
▸ PTGS2 known ✓ P35354 3/20 0.43
▸ THRB P10828 1/20 0.60
▸ GSR P00390 2/20 0.53
▸ ITGB3 P05106 1/20 0.47
▸ ITGA2B P08514 1/20 0.47
▸ CPB2 Q96IY4 2/20 0.45
▸ MMP2 P08253 1/20 0.44
▸ S1PR2 O95136 1/20 0.44
▸ S1PR1 P21453 1/20 0.44
▸ S1PR3 Q99500 1/20 0.44
▸ GRM8 O00222 1/20 0.44
▸ GRM6 O15303 1/20 0.44
▸ GRIN2D O15399 1/20 0.44
▸ GRIN3B O60391 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ GRIK1 P39086 1/20 0.44
▸ GRM5 P41594 1/20 0.44
▸ GRIA1 P42261 1/20 0.44
▸ GRIA2 P42262 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL11276606 0.92 THRB (0.58) THRBGSRITGB3ITGA2BCPB2
(R)-Ibuprophen SCHEMBL29696062 0.84 THRB (0.73) THRBGSRITGB3ITGA2BMMP2
Dexibuprofen SCHEMBL8733957 0.84 THRB (0.73) THRBGSRITGB3ITGA2BMMP2
Ibuprofen SCHEMBL44616 0.84 THRB (0.73) THRBGSRITGB3ITGA2BMMP2
(R)-Ibuprophen SCHEMBL8579043 0.84 THRB (0.73) THRBGSRITGB3ITGA2BMMP2
Ibuprofen SCHEMBL44617 0.84 THRB (0.73) THRBGSRITGB3ITGA2BMMP2
Dexibuprofen SCHEMBL875767 0.84 THRB (0.73) THRBGSRITGB3ITGA2BMMP2
Dexibuprofen SCHEMBL379398 0.83 THRB (0.72) THRBGSRITGB3ITGA2BMMP2
Ibuprofen SCHEMBL8902943 0.83 THRB (0.72) THRBGSRITGB3ITGA2BMMP2
Ibuprofen SCHEMBL8902948 0.83 THRB (0.72) THRBGSRITGB3ITGA2BMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0253083-B1 Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment LISAPHARMA SPA (IT) 1994-08-31 — — EP claimed
US-4755533-A Topical vaginal use of lysine p-isobutylphenylpropionate in anti-inflammatory treatment LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA SPA (IT) 1988-07-05 — — US claimed
EP-0253083-A2 Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A. (IT) 1988-01-20 — — EP claimed
EP-0253083-B1 Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment LISAPHARMA SPA (IT) 1994-08-31 — — EP disclosed
EP-0253083-B1 Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment LISAPHARMA SPA (IT) 1994-08-31 — — EP disclosed
US-4755533-A Topical vaginal use of lysine p-isobutylphenylpropionate in anti-inflammatory treatment LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA SPA (IT) 1988-07-05 — — US disclosed
US-4755533-A Topical vaginal use of lysine p-isobutylphenylpropionate in anti-inflammatory treatment LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA SPA (IT) 1988-07-05 — — US disclosed
US-4755533-A Topical vaginal use of lysine p-isobutylphenylpropionate in anti-inflammatory treatment LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA SPA (IT) 1988-07-05 — — US disclosed
EP-0253083-A2 Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A. (IT) 1988-01-20 — — EP disclosed
EP-0253083-A2 Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A. (IT) 1988-01-20 — — EP disclosed
EP-0253083-A2 Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A. (IT) 1988-01-20 — — EP disclosed
Send feedback